Centers for Medicare & Medicaid Services announced that the federal healthcare program will cover the costs of cancer gene tests that have been approved by the Food and Drug Administration

16:48 EDT 23 Mar 2018 | Leaders in Pharmaceutical Business Intelligence

Centers for Medicare & Medicaid Services announced that the federal healthcare program will cover the costs of cancer gene tests that have been approved by the Food and Drug Administration   Reporter: Aviva Lev-Ari, PhD, RN genetic testing just became routine care for patients with advanced cancers. And that means precision medicine has finally broken into the mainstream. Any […]

Original Article: Centers for Medicare & Medicaid Services announced that the federal healthcare program will cover the costs of cancer gene tests that have been approved by the Food and Drug Administration

NEXT ARTICLE

More From BioPortfolio on "Centers for Medicare & Medicaid Services announced that the federal healthcare program will cover the costs of cancer gene tests that have been approved by the Food and Drug Administration"